Skip to main content

Table 4 Comparsion of outcome variables characterizing the measurement of the SP, SPAP variable at baseline and after application of KT between injured and healthy side in Placebo group

From: Does kinesiotaping can improve static stability of the knee after anterior cruciate ligament rupture? A randomized single-blind, placebo‐controlled trial

 

Baseline

Post

X difference

(95 % CI)

pa

ESa

X ± SD

X ± SD

SP

[mm]

Placebo

injured

1073.9 ± 266.5

1033.1 ± 289.2

-40.8 (1.45 to 2.56)

0.060

0.14

Placebo

healthy

967.3 ± 219.77

934.8 ± 285.1

-32.5 (1.24 to 1.64)

0.104

0.12

pb

0.049

0.045

   
 

ESb

0.43

0.34

   

SPAP

[mm]

Placebo

injured

702.4 ± 219.3

698.1 ± 217.5

-4.3 (1.01 to 3.01)

0.067

0.01

Placebo

healthy

625.8 ± 234.1

616.9 ± 237.6

-8.9 (1.32 to 1.84)

0.269

0.03

pb

0.027

0.018

   
 

ESb

0.33

0.35

   

SPML

[mm]

Placebo

injured

752.1 ± 208.6

728.6 ± 194.8

-63.5 (1.26 to 2.69)

0.221

0.11

Placebo

healthy

690.4 ± 276.3

683.9 ± 230.2

-6,5 (1.23 to 1.54)

0.138

0.02

pb

0.038

0.011

   
 

ESb

0.25

0.23

   

MV

[mm/s]

Placebo

injured

37.3 ± 9.9

35.6 ± 9.5

-1.7 (1.11 to 2.34)

0.089

0.17

Placebo

healthy

32.4 ± 5.6

31.8 ± 4.7

-0.6 (0.97 to 2.45)

0.076

0.11

pb

0.043

0.047

   

ESb

0.60

0.50

   

MVAP

[mm/s]

Placebo

injured

23.8 ± 7.4

22.2 ± 7.9

-1.6 (1.22 to 2.62)

0.079

0.20

Placebo

healthy

19.5 ± 5.9

18.9 ± 3.8

-0.6 (0.21 to 1.31)

0.139

0.12

pb

0.039

0.042

   

ESb

0.64

0.53

   

MVML

[mm/s]

Placebo

injured

25.1 ± 6.4

23.1 ± 6.2

-2 (1.29 to 2.97)

0.112

0.31

Placebo

healthy

19.9 ± 3.9

19.5 ± 4.6

-0.4 (0.34 to 2.49)

0.177

0.10

pb

0.047

0.034

   

ESb

0.98

0.69

   
  1. Placebo injured – injured side; Placebo healthy – healthy side